Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RNAZ

Transcode Therapeutics, Inc.

CIK 0001829635 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$2.87
↓ 0.10 (-3.37%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$3.04M
P/E Ratio
-0.07
EPS
-52.59
Dividend Yield
Not covered
52W Position
0%
Beta
0.81

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-0.11
P/S
Not covered
EV/Revenue
Not covered
ROE
154.7%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 0%
$2.87$20.99

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$34.66M
Total Assets
$162.40M
Free Cash Flow
-$19.52M

Recent news